Last checked at 24 Sep 2021 09:02
LONDON MARKET OPEN: JD Sports falls after Nike cuts revenue forecast
LONDON MARKET OPEN: JD Sports falls after Nike cuts revenue forecast
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat2
AZN Share
Trades4,025
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,278.00
Bid:
12,276.00
Ask:
12,278.00
Change:
14.00 (0.11%)
Spread:
2.00 (0.016%)
Open:
12,268.00
High:
12,388.00
Low:
12,256.00
Prev. Close:
12,264.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.24 Sep 2021 08:28
LIVE MARKETS-Europe's shares slide, but still set for weekly gains
Sept 24 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comEUROPE'S SHARES SLIDE, BUT STILL SET FOR WEEKLY GAINS (0725 GMT)European s...
Read more24 Sep 2021 07:47
AstraZeneca's Lynparza meets primary endpoint in prostate cancer trial
AstraZeneca's Lynparza meets primary endpoint in prostate cancer trial
Read more24 Sep 2021 07:28
AstraZeneca reports latest positive results for 'Lynparza'
(Sharecast News) - AstraZeneca said on Friday that positive high-level results from the 'PROpel' phase 3 trial showed 'Lynparza', or olaparib, in combination with abiraterone, demonstrated a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) versus standard-of-care abiraterone, as a first-line treatment for men with metastatic castration-resistant prostate cancer (mCRPC), with or without homologous recombination repair (HRR) gene mutations.
Read more23 Sep 2021 17:58
Panama approaching herd immunity against COVID-19, president says
PANAMA CITY, Sept 23 (Reuters) - Panama is weeks away from achieving herd immunity against COVID-19 after vaccinating more than half its population of 4.2 million people, President Laurentino Cortizo said on Thursday at the United Nations General...
Read more23 Sep 2021 07:00
AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugs
By Alistair SmoutLONDON, Sept 23 (Reuters) - AstraZeneca Plc on Thursday struck a deal with the firm behind Imperial College London's experimental COVID-19 vaccine to develop and sell drugs based on its self-amplifying RNA technology platform in o...
Read more23 Sep 2021 04:52
Japan doubles COVID-19 vaccine donation pledge to 60 mln doses
TOKYO, Sept 23 (Reuters) - Japan will double its COVID-19 vaccine donations to about 60 million doses intended for needy countries, Prime Minister Yoshihide Suga said at a virtual summit on Thursday.The pledge adds to a previous agreement https://...
Read more22 Sep 2021 13:40
Lithuania donates more COVID-19 vaccines to Taiwan
VILNIUS, Sept 22 (Reuters) - Lithuania will donate 235,900 additional doses of AstraZeneca COVID-19 vaccine to Taiwan, the European Union nation said on Wednesday, after angering China by allowing Taiwan to open a representative office under its ...
Read more22 Sep 2021 09:16
TOP NEWS: Oxford BioMedica sales double; Serum Institute buys stake
TOP NEWS: Oxford BioMedica sales double; Serum Institute buys stake
Read more21 Sep 2021 12:10
UPDATE 2-EU says people vaccinated with AstraZeneca shots should be able to travel to U.S.
(adds CDC guidance)BRUSSELS, Sept 21 (Reuters) - The European Commission said on Tuesday it would make sense for the United States to allow travel by people vaccinated with the AstraZeneca COVID-19 shots, although existing U.S. guidance already a...
Read more21 Sep 2021 12:10
UPDATE 1-EU says people vaccinated with AstraZeneca shots should be able to travel to U.S.
(Adds details)BRUSSELS, Sept 21 (Reuters) - The European Commission said on Tuesday it would make sense for the United States to allow travel by people vaccinated with the AstraZeneca COVID-19 shots which have yet to be approved by U.S. regulators...
Read more21 Sep 2021 11:24
EU says people vaccinated with AstraZeneca should be able to travel to U.S.
BRUSSELS, Sept 21 (Reuters) - The European Commission said on Tuesday it would make sense for the United States to allow travel by people vaccinated with the AstraZeneca shot in Europe.On Monday the White House said it would lift restrictions tha...
Read more21 Sep 2021 10:53
Indian foreign minister urges UK to resolve COVID quarantine dispute
By Alasdair Pal and Sanjeev MiglaniNEW DELHI, Sept 21 (Reuters) - India's foreign minister on Tuesday urged Britain to remove a rule requiring Indians visiting there to quarantine even if they are fully vaccinated.India's Covishield vaccine, develo...
Read more21 Sep 2021 09:14
UPDATE 2-FTSE 100 recovers 1% on energy, healthcare stock boost; Entain jumps
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Kingfisher top FTSE 100 loser despite positive results* Royal Dutch Shell sells U.S. oilfield assets* Stagecoast surges on merger talks wit...
Read more21 Sep 2021 08:36
AstraZeneca to invest USD360 million in Irish manufacturing facility
AstraZeneca to invest USD360 million in Irish manufacturing facility
Read more